These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6177552)

  • 1. Enhanced expression of cellular receptors for human interferon alpha on peripheral lymphocytes from patients with Down's syndrome.
    Mogensen KE; Vignaux F; Gresser I
    FEBS Lett; 1982 Apr; 140(2):285-7. PubMed ID: 6177552
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Interferon levels in Down's syndrome.
    Boyer JM; Fontes AK
    J Am Osteopath Assoc; 1975 Dec; 75(4):437-41. PubMed ID: 129490
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene dosage and down-regulation of the alpha-interferon receptor.
    Gerdes AM; Hørder M; Bonnevie-Nielsen V
    Scand J Clin Lab Invest; 1992 May; 52(3):189-92. PubMed ID: 1384107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.
    Fujii N; Oguma K; Fujii M; Fukatsu R; Takahata N; Kitabatake M
    Clin Exp Immunol; 1987 Apr; 68(1):168-76. PubMed ID: 2443283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxal phosphate in lymphocytes, polymorphonuclear leukocytes, and platelets in Down's syndrome.
    Mahuren JD; Coburn SP
    Am J Clin Nutr; 1974 May; 27(5):521-7. PubMed ID: 4274684
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of increased gene dosage expression on the alpha-interferon receptors in Down's syndrome.
    Gerdes AM; Hørder M; Petersen PH; Bonnevie-Nielsen V
    Biochim Biophys Acta; 1993 Apr; 1181(2):135-40. PubMed ID: 8481402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotic delay in peripheral blood lymphocytes and fibroblast cultures obtained from a child with Down's syndrome and from a healthy child.
    Major J
    Acta Med Hung; 1994; 50(1-2):109-15. PubMed ID: 7638036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid cell lines. Established from peripheral blood of persons with Down's syndrome.
    Woods LK; Moore GE; Bainbridge CJ; Huang CC; Huzella C; Quinn LA
    N Y State J Med; 1973 Apr; 73(7):869-73. PubMed ID: 4266330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiosensitivity of chromosomes in lymphocytes from Down's syndrome patients].
    Akif'ev AP; Mutovin GR; Filiushkin IV; Khandogina EK
    Biull Eksp Biol Med; 1983 Dec; 96(12):69-71. PubMed ID: 6229291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodeficiency in Down's syndrome: analysis by OKT monoclonal antibodies.
    Bertotto A; Gerli R; Fabietti G; Arcangeli CD; Bianchi S; Vaccaro R
    Thymus; 1984; 6(6):365-7. PubMed ID: 6084348
    [No Abstract]   [Full Text] [Related]  

  • 14. An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome.
    Hahn T; Levin S; Handzel ZT; Ashkenazi A; Chemke J; Shterk V
    Isr J Med Sci; 1979 Sep; 15(9):775-8. PubMed ID: 159876
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystalline bodies in lymphocytes of patients with Down's syndrome.
    Smith GF; Penrose LS; O'Hara PT
    Lancet; 1967 Aug; 2(7513):452-3. PubMed ID: 4166111
    [No Abstract]   [Full Text] [Related]  

  • 16. Free interleukin-2 receptors in children with trisomy 21 (Down's syndrome) and different levels of periodontal disease.
    Cutando-Soriano A; Gómez-Moreno G; Bravo M
    Int J Paediatr Dent; 1998 Sep; 8(3):177-80. PubMed ID: 17294624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers.
    Wald NJ; Bestwick JP; George LM; Wu T; Morris JK
    J Med Screen; 2012 Jun; 19(2):60-7. PubMed ID: 22547409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of real-time fluorescence quantitative PCR accompanied with comparison of Delta CT for diagnosis of Down's syndrome from a single cell].
    Yu R; Chen HP; Yan XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):200-2. PubMed ID: 17407082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of changes in the nuclear chromatin of peripheral blood lymphocytes in Down's syndrome.
    Fedorova KN
    Bull Exp Biol Med; 1974 Aug; 77(2):188-90. PubMed ID: 4140002
    [No Abstract]   [Full Text] [Related]  

  • 20. CD3+/CD30+ circulating T lymphocytes are markedly increased in older subjects with Down's syndrome (Trisomy 21).
    Bertotto A; Crupi S; Fabietti GM; Troiani S; Parente C; Mezzetti D; Vaccaro R
    Pathobiology; 1999; 67(2):108-10. PubMed ID: 10023139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.